直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

When to Consider Expert Testimony for Special Purpose Computer-Implemented Means-Plus-Function Claims

October 20, 2023

Authored and Edited by Emma N. Ng; Ryan V. McDonnell; Esther H. Lim

In Sisvel International S.A. v. Sierra Wireless, Inc., Nos. 2022-1493, 2022-1547 (Fed. Cir. Oct. 6, 2023), the Federal Circuit affirmed-in-part, vacated-in-part, and remanded to the Patent Trial and Appeal Board (“Board”).

Cross-Appellants filed a petition for an IPR of claims 1-10 of U.S. Patent No. 6,529,561 (“the ’561 patent”). The ’561 patent relates to methods of channel coding when transmitting data in radio systems. After instituting the IPR, the Board found claims 1-3 and 9 unpatentable for obviousness and claims 4-8 and 10 not unpatentable. The claims were examined under pre-AIA law.

The Federal Circuit held that the Board erred in analyzing the “means for detection” limitation of claims 5 and 10. The Court noted that its precedents recognize two distinct groups for special purpose computer-implemented means-plus-functions claims: (1) where a defining structure is totally absent from the specification and expert testimony cannot be considered; or (2) where a defining structure is “arguably” adequately disclosed in the specification and expert testimony may be considered. While the Board determined that the “means for detection” limitation fell into the first group and did not consider expert testimony, the Federal Circuit disagreed because the specification identified the name of relevant software protocols. Thus, the limitation properly fell into the second group even though the steps corresponding to the protocols were not expressly described in the specification. The Federal Circuit thus remanded for the Board to consider expert testimony and address whether the protocols identified disclosed a sufficient structure to satisfy 35 U.S.C. § 112.

Tags

Written description (35 USC § 112), means-plus-function claim

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Global IP Enforcement, Litigation, and Trials

Related Industries

Communications

Related Offices

Washington, DC

Contacts

Emma N. Ng
Associate
Washington, DC
+1 202 408 4149
Email
Ryan V. McDonnell
Associate
Washington, DC
+1 202 408 4167
Email
Esther H. Lim
Partner and Chief Community Officer
Washington, DC
+1 202 408 4121
Email

Copyright © 2023 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

IP Life Sciences Forum 2026

December 13-15, 2026

Coral Gables

Webinar

Data and Market Exclusivity: An Update on China’s New Law and Comparisons to the US and Europe

November 19, 2026

Webinar

Conference

IPBC Asia 2026

November 17-19, 2026

Tokyo

Conference

NAPABA Convention 2026

November 12-14, 2026

Los Angeles

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Conference

31st Annual UMass Chan Research Retreat

October 15, 2026

Worcester

Conference

2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada

October 14-16, 2026

New York

Articles

California Court Considers CIPA’s Application to Online Tracking as New Law Limits Private Actions

October 7, 2026

INCONTESTABLE® Blog

Federal Court Orders Rebel Creamery to Redesign Packaging and Disgorge $23.8 Million in Van Leeuwen Trade Dress Case

October 7, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP